The effects of prior calcium channel blocker therapy on creatine kinase-MB levels after percutaneous coronary interventions

Article English OPEN
Gulmez, Oyku;

Oyku Gulmez, Ilyas Atar, Bülent Ozin, Mehmet Emin Korkmaz, Aslı Atar, Alp Aydinalp, Aylin Yildirir, Haldun MuderrisogluBaskent University Faculty of Medicine, Department of Cardiology, Ankara, TurkeyBackground: Use of intracoronary calcium channel blockers (CC... View more
  • References (30)
    30 references, page 1 of 3

    Abdelmeguid AE, Topol EJ, Whitlow PL, et al. 1996. Significance of mild transient release of creatine kinase-MB fraction after percutaneous coronary interventions. Circulation, 94:1528-36.

    Abdelmeguid AE, Topol EJ. 1996. The myth of the myocardial 'infarctlet' during percutaneous coronary revascularization procedures. Circulation, 94:3369-75.

    Akkerhuis KM, Alexander JH, Tardiff BE, et al. 2002. Minor myocardial damage and prognosis. Circulation, 105:554-6.

    Aronow HD, McRae T, Quinn MJ. 2002b. Patients on lipid-lowering therapy at the time of myocardial infarction have smaller infarcts: further evidence to suggest a salutary effect in acute coronary syndrome [abstract]. J Am Coll Cardiol, 39:318A.

    Aronow HD, Quinn MJ, Gurm HS. 2002a. Myocardial necrosis is halved in patients undergoing elective percutaneous coronary intervention who are pretreated with lipid-lowering therapy [abstract]. J Am Coll Cardiol, 39:32A.

    Bestehorn HP, Neumann FJ, Büttner HJ, et al. 2004. Evaluation of the oral verapamil on clinical outcome and angiographic restenosis after percutaneous coronary intervention. The randomized, double-blind, placebo-controlled, multicenter verapamil slow-release for prevention of cardiovascular events after angioplasty (VESPA) trial. J Am Coll Cardiol, 43:2160-5.

    Califf RM, Abdelmeguid AE, Kuntz RE, et al. 1998. Myonecrosis after revascularization procedures. J Am Coll Cardiol, 31:241-51.

    Demir I, Yılmaz H, Ermi¸s C, et al. 2002. Treatment of no re-flow phenomenon with verapamil after primary stent deployment during myocardial infarction. Jpn Heart J, 43:573-80.

    Dens J, Desmet W, Piessens J. 2003. An updated meta-analysis of calcium-channel blockers in the prevention of restenosis after coronary angioplasty. Am Heart J, 145:404-8.

    Desmet WJ, Dens J, Coussement P, et al. 2002. Does adenosine prevent myocardial micronecrosis following percutaneous coronary intervention? The ADELINE pilot trial. ADEnosine Limit myocardial Necrosis. Heart, 88:293-5.

  • Similar Research Results (1)
  • Metrics
Share - Bookmark